Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$5.03 – $15.21
10% from low
Exchange
OTC Link
ADRC
Borrow rate
0.25%
Easy to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $114.72B | $116.64B | $121.89B | $137.48B | $144.18B | $148.25B | $160.23B | $181.07B |
| Cost of revenue | $50.95B | $53.16B | $49.95B | $50.19B | $55.98B | $51.24B | $51.12B | $60.93B |
| Gross profit | $63.76B | $63.48B | $71.93B | $87.29B | $88.19B | $97.02B | $109.12B | $120.14B |
| Gross margin | 55.6% | 54.4% | 59.0% | 63.5% | 61.2% | 65.4% | 68.1% | 66.4% |
| R&D | $16.70B | $13.99B | $16.10B | $22.86B | $24.14B | $31.68B | $34.34B | $38.93B |
| Operating income | $20.64B | $21.67B | $26.13B | $32.95B | $30.05B | $31.39B | $36.76B | $35.03B |
| EBITDA | $24.96B | $25.91B | $32.09B | $38.01B | $35.67B | $36.29B | $41.47B | $42.05B |
| Net income | $16.30B | $16.87B | $19.54B | $24.99B | $22.81B | $25.85B | $32.56B | $31.51B |
| Net margin | 14.2% | 14.5% | 16.0% | 18.2% | 15.8% | 17.4% | 20.3% | 17.4% |
| EPS (diluted) | 60.51 | 62.60 | 72.53 | 92.74 | 84.68 | 95.96 | 120.82 | 116.64 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2027 | $193.0B | $0.00 | $0.00–$0.00 | 0 |
| 2028 | $187.2B | $0.00 | $0.00–$0.00 | 0 |
Forward consensus · source: Financial Modeling Prep
NIPPON SHINYAKU UNSP/ADR
No one on the platform currently holds NPPNY.
No tracked institution reports a position in NPPNY as of their last filing.
No one on the platform has traded NPPNY yet.
| +0.00% |
| $818M |
| — |
| GTBIFGreen Thumb Industries Inc. | $7.64 | +2.00% | $1.8B | — |
| KSPHFKissei Pharmaceutical Co., Ltd. | $25.77 | +0.00% | $1.1B | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 0.0× earnings vs its 0.1× historical median P/E.
Fair value ≈ $8.25 · price $6.00 today
Fair-value line = the stock's median historical P/E × earnings. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.